Altitude Related Illness In Patients With Respiratory Disease
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Randomized, placebo controlled trial evaluating efficacy of dexamethasone in preventing acute
mountain sickness in lowlanders with chronic obstructive lung disease travelling from 700 m
to 3200 m.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Collaborator:
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov